000 01268 a2200361 4500
005 20250514063637.0
264 0 _c20030610
008 200306s 0 0 eng d
022 _a1568-0118
024 7 _a10.2174/1568011023353651
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTenzer, A
245 0 0 _aSignal transduction inhibitors as radiosensitizers.
_h[electronic resource]
260 _bCurrent medicinal chemistry. Anti-cancer agents
_cNov 2002
300 _a727-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRadiation-Sensitizing Agents
_xpharmacology
650 0 4 _aRadiotherapy
_xadverse effects
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aZingg, D
700 1 _aRiesterer, O
700 1 _aVuong, V
700 1 _aBodis, S
700 1 _aPruschy, M
773 0 _tCurrent medicinal chemistry. Anti-cancer agents
_gvol. 2
_gno. 6
_gp. 727-42
856 4 0 _uhttps://doi.org/10.2174/1568011023353651
_zAvailable from publisher's website
999 _c12471390
_d12471390